Adalimumab Injection

Adalimumab Injection

Categories : Immunology

Product Packaging : 0.8 ml

Product Composition : 40 mg

Send Message

Adalimumab Injection is a recombinant monoclonal antibody used in the management of autoimmune and inflammatory disorders. It works by specifically targeting and inhibiting tumor necrosis factor-alpha (TNF-α), a key cytokine involved in inflammatory processes, thereby reducing inflammation and disease progression.

This biologic therapy is widely used in conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and plaque psoriasis. The injectable formulation ensures targeted and sustained therapeutic action, improving patient outcomes in chronic inflammatory diseases.

Genliva Wellness LLP is a trusted adalimumab injection contract manufacturer India, delivering high-quality biologic formulations for domestic markets, exports, and adalimumab injection third party manufacturer India services.

Adalimumab injection is a monoclonal antibody designed to neutralize tumor necrosis factor-alpha (TNF-α), a key mediator of inflammation. The formulation provides targeted immunomodulation for chronic inflammatory and autoimmune conditions.

  • Fully human monoclonal antibody targeting TNF-α
  • Suppresses inflammatory pathways at the cytokine level
  • Designed for precise immunomodulatory action
  • Suitable for subcutaneous administration
  • Enables sustained control of inflammatory activity
  • Developed under advanced biopharmaceutical manufacturing standards

This medication is used in the treatment of various autoimmune and inflammatory disorders where TNF-α plays a central role. It helps reduce disease activity and improve quality of life.

  • Rheumatoid arthritis
  • Ankylosing spondylitis
  • Psoriatic arthritis
  • Plaque psoriasis
  • Crohn’s disease and ulcerative colitis
  • Juvenile idiopathic arthritis

The formulation offers targeted biologic therapy with long-term disease control and improved patient outcomes in chronic conditions.

  • Targets root inflammatory pathways rather than symptoms
  • Supports sustained disease remission and control
  • Reduces joint damage and disease progression
  • Suitable for chronic therapy under specialist care
  • Enables convenient subcutaneous dosing schedule
  • High-quality biologic formulation for clinical reliability

whatsapp-app